Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 412 entries
View as:

Reducing Nephrotoxicity of Vancomycin: A Prospective Study of Continuous Versus Intermittent Infusion of Vancomycin

Phase: N/A Priority: Normal
NCT ID: NCT01720940 Org: User:
Start: 10/31/12 End: 09/30/15 Due: 09/30/16

CURATE.AI Optimized Modulation for Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT03759093 Org: User:
Start: 09/10/23 End: 09/10/25 Due: 09/10/26

Reducing Inflammatory Syndrome in Surgery - Colorectal (RISIS-CR) Trial

Phase: N/A Priority: Normal
NCT ID: NCT06646809 Org: User:
Start: 05/09/24 End: 12/31/24 Due: 12/31/25

Evaluation of Somatostatin Receptor Imaging Using PET/MRI as a Novel Approach to Detecting Pathology in Pulmonary TB

Phase: N/A Priority: Normal
NCT ID: NCT02845570 Org: User:
Start: 07/31/16 End: - Due: -

Study of Circulating and Tumor Biomarkers in Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01866202 Org: User:
Start: 03/31/12 End: - Due: -

Reactivating NK Cells in Treating Refractory Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02507154 Org: User:
Start: 07/31/15 End: 08/31/19 Due: 08/31/20

Pre- and Apnoeic Oxygenation for RSI in ED

Phase: N/A Priority: Normal
NCT ID: NCT03396094 Org: User:
Start: 05/07/18 End: 07/31/20 Due: 07/31/21

Development of a Clinical Decision Support System With Artificial Intelligence for Cancer Care

Phase: N/A Priority: Normal
NCT ID: NCT04675138 Org: User:
Start: 08/20/20 End: 12/31/24 Due: 12/31/25

Quadratic Phenotypic Optimisation Platform (QPOP) Utilisation to Enhance Selection of Patient Therapy Through Patient Derived Organoids in Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05177432 Org: User:
Start: 12/06/21 End: 12/31/25 Due: 12/31/26

Left Ventricular Pacing to Prevent Iatrogenic TR Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT02314897 Org: User:
Start: 01/31/15 End: 12/31/18 Due: 12/31/19

Crisis Resource Management Improvement Through Intellectual Questioning of Authority

Phase: N/A Priority: Normal
NCT ID: NCT03707964 Org: User:
Start: 03/11/19 End: 11/20/20 Due: 11/20/21

Efficacy and Toxicity Study of Pomalidomide and Dexamethasone in Patients Who Have Relapsed After Exposure to Lenalidomide and Bortezomib

Phase: N/A Priority: Normal
NCT ID: NCT02158702 Org: User:
Start: 11/30/14 End: 11/30/18 Due: 11/30/19

Effects of Horticultural Therapy on Elderly at Risk of Cognitive Decline

Phase: N/A Priority: Normal
NCT ID: NCT03045718 Org: User:
Start: 01/01/17 End: 12/01/19 Due: 12/01/20

ALaCART-B: Acute Leukemia and Chimeric Antigen Receptor-T Cell Therapy for B-lymphoblastic Leukemia.

Phase: N/A Priority: Normal
NCT ID: NCT05038696 Org: User:
Start: 04/28/21 End: 08/01/26 Due: 08/01/27

Pulsed Electromagnetic Fields in Preventing Physical Deconditioning in Patients Undergoing Prolonged Hospitalization

Phase: N/A Priority: Normal
NCT ID: NCT06744764 Org: User:
Start: 04/17/23 End: 12/31/25 Due: 12/31/26

A Study of Serum Protein Profiling in Patients With Non-Small Cell Lung Cancer Treated With Gefitinib or Erlotinib

Phase: N/A Priority: Normal
NCT ID: NCT00717847 Org: User:
Start: 02/28/06 End: 04/30/13 Due: 04/30/14

Trial of Lenvatinib Plus PembrolizumAb in Recurrent Gynecological Clear Cell Adenocarcinomas (LARA)

Phase: N/A Priority: Normal
NCT ID: NCT04699071 Org: User:
Start: 02/18/21 End: 01/31/25 Due: 01/31/26

Assessing the Clinical Benefits of a Pharmacogenetics-Guided Dosing Regiment for Calculating Warfarin Maintenance Dose

Phase: N/A Priority: Normal
NCT ID: NCT00700895 Org: User:
Start: 08/31/06 End: 08/31/17 Due: 08/31/18

Study of Non-Myeloablative Haplo-identical Haematopoietic Stem Cell Transplantation in Patients With Haematological Malignancies or Acquired Aplastic Anaemia

Phase: N/A Priority: Normal
NCT ID: NCT01719341 Org: User:
Start: 09/30/12 End: - Due: -

Use of Tragus Pressure in Guiding Emergence From Anaesthesia

Phase: N/A Priority: Normal
NCT ID: NCT04331756 Org: User:
Start: 07/01/17 End: 03/19/21 Due: 03/19/22

Q-GAIN (Using Qpop to Predict Treatment for GAstroIntestinal caNcer)

Phase: N/A Priority: Normal
NCT ID: NCT04611035 Org: User:
Start: 01/20/20 End: 01/31/23 Due: 01/31/24

Familial Cancer Registry and DNA Bank

Phase: N/A Priority: Normal
NCT ID: NCT02083224 Org: User:
Start: 01/31/00 End: - Due: -

Pulsed Electromagnetic Fields (PEMFs) - A Highly Selective Breast CAncer Treatment pLatform (PASCAL)

Phase: N/A Priority: Normal
NCT ID: NCT06332508 Org: User:
Start: 12/30/22 End: 12/31/25 Due: 12/31/26

Detection of Minimal Change Esophagitis Using Confocal Laser Endomicroscopy

Phase: N/A Priority: Normal
NCT ID: NCT00954070 Org: User:
Start: 08/31/09 End: 04/30/12 Due: 04/30/13

Detection of EGFR Mutations in the Blood of Patients With Non-small Cell Lung Cancer: a Feasibility Study

Phase: N/A Priority: Normal
NCT ID: NCT00717002 Org: User:
Start: 02/29/08 End: 04/30/13 Due: 04/30/14